

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | muscle filament sliding (GO:0030049) | 8.93871155 |
| 2 | actin-myosin filament sliding (GO:0033275) | 8.93871155 |
| 3 | actin-mediated cell contraction (GO:0070252) | 7.42320318 |
| 4 | skeletal muscle contraction (GO:0003009) | 7.34811478 |
| 5 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 6.72352346 |
| 6 | regulation of skeletal muscle contraction (GO:0014819) | 6.50368567 |
| 7 | actin filament-based movement (GO:0030048) | 5.62100627 |
| 8 | striated muscle contraction (GO:0006941) | 5.25959112 |
| 9 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 5.24463140 |
| 10 | response to muscle activity (GO:0014850) | 5.05125865 |
| 11 | ribosomal small subunit assembly (GO:0000028) | 5.02037065 |
| 12 | sarcomere organization (GO:0045214) | 5.00588011 |
| 13 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 4.74985070 |
| 14 | myofibril assembly (GO:0030239) | 4.74014594 |
| 15 | regulation of relaxation of muscle (GO:1901077) | 4.60725731 |
| 16 | formation of translation preinitiation complex (GO:0001731) | 4.59127411 |
| 17 | skeletal muscle fiber development (GO:0048741) | 4.58805603 |
| 18 | viral transcription (GO:0019083) | 4.57184225 |
| 19 | maturation of SSU-rRNA (GO:0030490) | 4.56655255 |
| 20 | translational termination (GO:0006415) | 4.50285461 |
| 21 | plasma membrane repair (GO:0001778) | 4.34082379 |
| 22 | response to inactivity (GO:0014854) | 4.32555054 |
| 23 | cardiac muscle contraction (GO:0060048) | 4.19948323 |
| 24 | translational elongation (GO:0006414) | 4.19075451 |
| 25 | ribosomal large subunit biogenesis (GO:0042273) | 4.16967053 |
| 26 | negative regulation of protein localization to cell surface (GO:2000009) | 4.16697890 |
| 27 | creatine metabolic process (GO:0006600) | 4.14853886 |
| 28 | ribosomal small subunit biogenesis (GO:0042274) | 4.10982001 |
| 29 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 4.10372097 |
| 30 | myotube cell development (GO:0014904) | 4.09612135 |
| 31 | muscle contraction (GO:0006936) | 4.04660149 |
| 32 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 4.01856894 |
| 33 | translational initiation (GO:0006413) | 4.00994614 |
| 34 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 3.98948052 |
| 35 | IMP biosynthetic process (GO:0006188) | 3.98524816 |
| 36 | glycogen catabolic process (GO:0005980) | 3.88610426 |
| 37 | cardiac myofibril assembly (GO:0055003) | 3.88346290 |
| 38 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.86783903 |
| 39 | skeletal muscle adaptation (GO:0043501) | 3.86390678 |
| 40 | muscle cell cellular homeostasis (GO:0046716) | 3.85122007 |
| 41 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 3.84776132 |
| 42 | regulation of gene silencing by RNA (GO:0060966) | 3.81656528 |
| 43 | regulation of posttranscriptional gene silencing (GO:0060147) | 3.81656528 |
| 44 | regulation of gene silencing by miRNA (GO:0060964) | 3.81656528 |
| 45 | NADH metabolic process (GO:0006734) | 3.81089888 |
| 46 | regulation of translational fidelity (GO:0006450) | 3.78750826 |
| 47 | protein targeting to ER (GO:0045047) | 3.76310583 |
| 48 | cotranslational protein targeting to membrane (GO:0006613) | 3.74972700 |
| 49 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.73175649 |
| 50 | actomyosin structure organization (GO:0031032) | 3.70978788 |
| 51 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 3.70463398 |
| 52 | IMP metabolic process (GO:0046040) | 3.67046179 |
| 53 | muscle system process (GO:0003012) | 3.65647366 |
| 54 | glucan catabolic process (GO:0009251) | 3.61000942 |
| 55 | cellular protein complex disassembly (GO:0043624) | 3.59421608 |
| 56 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.58864346 |
| 57 | heart process (GO:0003015) | 3.58124587 |
| 58 | heart contraction (GO:0060047) | 3.58124587 |
| 59 | viral life cycle (GO:0019058) | 3.57824151 |
| 60 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 3.57124630 |
| 61 | cellular polysaccharide catabolic process (GO:0044247) | 3.54955031 |
| 62 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.53665579 |
| 63 | DNA strand elongation (GO:0022616) | 3.49635914 |
| 64 | skeletal muscle tissue development (GO:0007519) | 3.48197201 |
| 65 | hemidesmosome assembly (GO:0031581) | 3.47941142 |
| 66 | protein localization to endoplasmic reticulum (GO:0070972) | 3.47111331 |
| 67 | DNA replication initiation (GO:0006270) | 3.45921003 |
| 68 | ribonucleoprotein complex biogenesis (GO:0022613) | 3.44586875 |
| 69 | striated muscle atrophy (GO:0014891) | 3.44246824 |
| 70 | DNA deamination (GO:0045006) | 3.38378757 |
| 71 | muscle cell fate commitment (GO:0042693) | 3.38306996 |
| 72 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 3.32518345 |
| 73 | positive regulation of myotube differentiation (GO:0010831) | 3.31590876 |
| 74 | glycogen biosynthetic process (GO:0005978) | 3.30986839 |
| 75 | glucan biosynthetic process (GO:0009250) | 3.30986839 |
| 76 | skeletal muscle tissue regeneration (GO:0043403) | 3.29419622 |
| 77 | DNA unwinding involved in DNA replication (GO:0006268) | 3.29316842 |
| 78 | polysaccharide catabolic process (GO:0000272) | 3.26284375 |
| 79 | positive regulation of SMAD protein import into nucleus (GO:0060391) | 3.23499923 |
| 80 | folic acid-containing compound biosynthetic process (GO:0009396) | 3.21140651 |
| 81 | regulation of integrin-mediated signaling pathway (GO:2001044) | 3.20781525 |
| 82 | myoblast fusion (GO:0007520) | 3.20780492 |
| 83 | telomere maintenance via recombination (GO:0000722) | 3.19997081 |
| 84 | nucleobase biosynthetic process (GO:0046112) | 3.18322635 |
| 85 | regulation of cell communication by electrical coupling (GO:0010649) | 3.18029775 |
| 86 | tRNA aminoacylation (GO:0043039) | 3.17962853 |
| 87 | amino acid activation (GO:0043038) | 3.17962853 |
| 88 | protein complex disassembly (GO:0043241) | 3.17446422 |
| 89 | muscle fiber development (GO:0048747) | 3.16948002 |
| 90 | regulation of striated muscle contraction (GO:0006942) | 3.16374948 |
| 91 | translation (GO:0006412) | 3.15653347 |
| 92 | regulation of SMAD protein import into nucleus (GO:0060390) | 3.14861816 |
| 93 | mitotic nuclear envelope disassembly (GO:0007077) | 3.12218425 |
| 94 | muscle atrophy (GO:0014889) | 3.12180394 |
| 95 | tRNA aminoacylation for protein translation (GO:0006418) | 3.11844771 |
| 96 | ribosome assembly (GO:0042255) | 3.11562510 |
| 97 | regulation of actin filament-based movement (GO:1903115) | 3.09881049 |
| 98 | muscle tissue morphogenesis (GO:0060415) | 3.07570707 |
| 99 | nuclear pore organization (GO:0006999) | 3.03662478 |
| 100 | heterochromatin organization (GO:0070828) | 3.02842802 |
| 101 | regulation of receptor recycling (GO:0001919) | 3.02325347 |
| 102 | macromolecular complex disassembly (GO:0032984) | 3.01865436 |
| 103 | ribosome biogenesis (GO:0042254) | 3.01593738 |
| 104 | cardiac muscle tissue morphogenesis (GO:0055008) | 3.00980959 |
| 105 | syncytium formation by plasma membrane fusion (GO:0000768) | 3.00976471 |
| 106 | regulation of protein localization to cell surface (GO:2000008) | 3.00745772 |
| 107 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 3.00149375 |
| 108 | striated muscle adaptation (GO:0014888) | 3.00118149 |
| 109 | nuclear envelope disassembly (GO:0051081) | 2.99642292 |
| 110 | membrane disassembly (GO:0030397) | 2.99642292 |
| 111 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 2.98632953 |
| 112 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 2.98632953 |
| 113 | desmosome organization (GO:0002934) | 2.95056485 |
| 114 | telomere maintenance via telomere lengthening (GO:0010833) | 2.93793174 |
| 115 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 2.93767859 |
| 116 | mitotic recombination (GO:0006312) | 2.92204734 |
| 117 | regulation of protein heterodimerization activity (GO:0043497) | 2.91971665 |
| 118 | fructose metabolic process (GO:0006000) | 2.91582374 |
| 119 | nuclear pore complex assembly (GO:0051292) | 2.91060113 |
| 120 | positive regulation of myoblast differentiation (GO:0045663) | 2.90219426 |
| 121 | rRNA processing (GO:0006364) | 2.90129437 |
| 122 | spliceosomal snRNP assembly (GO:0000387) | 2.88176600 |
| 123 | extracellular fibril organization (GO:0043206) | 2.84105385 |
| 124 | regulation of the force of heart contraction (GO:0002026) | 2.83969181 |
| 125 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 2.83933893 |
| 126 | tricarboxylic acid cycle (GO:0006099) | 2.83041376 |
| 127 | cardiac muscle hypertrophy (GO:0003300) | 2.82904207 |
| 128 | somatic hypermutation of immunoglobulin genes (GO:0016446) | 2.82316979 |
| 129 | somatic diversification of immune receptors via somatic mutation (GO:0002566) | 2.82316979 |
| 130 | positive regulation of receptor recycling (GO:0001921) | 2.81620784 |
| 131 | nuclear-transcribed mRNA catabolic process (GO:0000956) | 2.80983340 |
| 132 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.80494769 |
| 133 | purine nucleobase biosynthetic process (GO:0009113) | 2.80370151 |
| 134 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.79658835 |
| 135 | rRNA metabolic process (GO:0016072) | 2.77471563 |
| 136 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 2.76158086 |
| 137 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.75463429 |
| 138 | establishment of integrated proviral latency (GO:0075713) | 2.75192579 |
| 139 | glycogen metabolic process (GO:0005977) | 2.73776306 |
| 140 | regulation of translational termination (GO:0006449) | 2.73766651 |
| 141 | DNA replication-dependent nucleosome organization (GO:0034723) | 2.73526543 |
| 142 | DNA replication-dependent nucleosome assembly (GO:0006335) | 2.73526543 |
| 143 | striated muscle hypertrophy (GO:0014897) | 2.73412840 |
| 144 | negative regulation of muscle contraction (GO:0045932) | 2.70412928 |
| 145 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 2.69743846 |
| 146 | mRNA catabolic process (GO:0006402) | 2.68717080 |
| 147 | regulation of calcium ion transmembrane transport (GO:1903169) | 2.67768952 |
| 148 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 2.67768952 |
| 149 | cellular glucan metabolic process (GO:0006073) | 2.66947205 |
| 150 | glucan metabolic process (GO:0044042) | 2.66947205 |
| 151 | response to activity (GO:0014823) | 2.65147426 |
| 152 | striated muscle cell development (GO:0055002) | 2.64081471 |
| 153 | protein localization to kinetochore (GO:0034501) | 2.64059427 |
| 154 | protein targeting to membrane (GO:0006612) | 2.63894299 |
| 155 | gluconeogenesis (GO:0006094) | 2.63132973 |
| 156 | RNA catabolic process (GO:0006401) | 2.62057746 |
| 157 | regulation of integrin activation (GO:0033623) | 2.61562634 |
| 158 | histone arginine methylation (GO:0034969) | 2.61439179 |
| 159 | pseudouridine synthesis (GO:0001522) | 2.61243022 |
| 160 | muscle adaptation (GO:0043500) | 2.60968456 |
| 161 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.60851930 |
| 162 | regulation of mitotic spindle organization (GO:0060236) | 2.57727229 |
| 163 | regulation of muscle contraction (GO:0006937) | 2.54760335 |
| 164 | relaxation of muscle (GO:0090075) | 2.54309622 |
| 165 | cell-substrate junction assembly (GO:0007044) | 2.53959753 |
| 166 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.53783082 |
| 167 | nucleobase-containing small molecule interconversion (GO:0015949) | 2.53677708 |
| 168 | peptidyl-arginine omega-N-methylation (GO:0035247) | 2.53560531 |
| 169 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.52465052 |
| 170 | cellular component biogenesis (GO:0044085) | 2.51930752 |
| 171 | G1/S transition of mitotic cell cycle (GO:0000082) | 2.51632165 |
| 172 | cell cycle G1/S phase transition (GO:0044843) | 2.51632165 |
| 173 | establishment or maintenance of monopolar cell polarity (GO:0061339) | 2.51502670 |
| 174 | establishment of monopolar cell polarity (GO:0061162) | 2.51502670 |
| 175 | fibril organization (GO:0097435) | 2.50884077 |
| 176 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.49591841 |
| 177 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.49591841 |
| 178 | DNA replication checkpoint (GO:0000076) | 2.49297516 |
| 179 | regulation of muscle system process (GO:0090257) | 2.49161320 |
| 180 | muscle organ development (GO:0007517) | 2.48864143 |
| 181 | pore complex assembly (GO:0046931) | 2.48777385 |
| 182 | epithelial cell-cell adhesion (GO:0090136) | 2.48560243 |
| 183 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.48432840 |
| 184 | chromatin remodeling at centromere (GO:0031055) | 2.48273300 |
| 185 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.48141649 |
| 186 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.48141649 |
| 187 | mitotic G1 DNA damage checkpoint (GO:0031571) | 2.47566717 |
| 188 | muscle hypertrophy (GO:0014896) | 2.47060451 |
| 189 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.46302565 |
| 190 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.46302565 |
| 191 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.46302565 |
| 192 | regulation of translational elongation (GO:0006448) | 2.46054068 |
| 193 | embryonic process involved in female pregnancy (GO:0060136) | 2.45944439 |
| 194 | muscle structure development (GO:0061061) | 2.45885700 |
| 195 | DNA geometric change (GO:0032392) | 2.45573708 |
| 196 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.44969868 |
| 197 | negative regulation of ligase activity (GO:0051352) | 2.44969868 |
| 198 | barbed-end actin filament capping (GO:0051016) | 2.43909112 |
| 199 | regulation of water loss via skin (GO:0033561) | 2.43637211 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 6.05355036 |
| 2 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 4.28375849 |
| 3 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.64458426 |
| 4 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 3.07454369 |
| 5 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.70065988 |
| 6 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.69145176 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.66069408 |
| 8 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.62794469 |
| 9 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.60723912 |
| 10 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.56668121 |
| 11 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.55902795 |
| 12 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.55595967 |
| 13 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.54629008 |
| 14 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.53404836 |
| 15 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.46724252 |
| 16 | * NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.37704941 |
| 17 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.37140348 |
| 18 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.36045705 |
| 19 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.35725381 |
| 20 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.28225756 |
| 21 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.26687200 |
| 22 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.25939279 |
| 23 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.18298258 |
| 24 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.15500057 |
| 25 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 2.15297260 |
| 26 | XRN2_22483619_ChIP-Seq_HELA_Human | 2.14650663 |
| 27 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.13010232 |
| 28 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.10937642 |
| 29 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 2.10103704 |
| 30 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 2.07147607 |
| 31 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 2.06549083 |
| 32 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 2.06549083 |
| 33 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 2.06360937 |
| 34 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.00813955 |
| 35 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.98058134 |
| 36 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.94040237 |
| 37 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.90258682 |
| 38 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.90025765 |
| 39 | * P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.86155636 |
| 40 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.85172936 |
| 41 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.84933266 |
| 42 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.84933266 |
| 43 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.84933266 |
| 44 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.83551761 |
| 45 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.80994680 |
| 46 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.80962579 |
| 47 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.80252348 |
| 48 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.79984268 |
| 49 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.79288789 |
| 50 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.76564468 |
| 51 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.71782102 |
| 52 | * LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.71658507 |
| 53 | * KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.71117396 |
| 54 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.69501442 |
| 55 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.67112556 |
| 56 | * ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.66442260 |
| 57 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.60835364 |
| 58 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.60577412 |
| 59 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.60204530 |
| 60 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.60161177 |
| 61 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.58656324 |
| 62 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.57486992 |
| 63 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.56889476 |
| 64 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.54863934 |
| 65 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.54756799 |
| 66 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.54523552 |
| 67 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.53417004 |
| 68 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.52506032 |
| 69 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.51276335 |
| 70 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.50412663 |
| 71 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.48592877 |
| 72 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.47361487 |
| 73 | * KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.46511685 |
| 74 | MYC_22102868_ChIP-Seq_BL_Human | 1.46033816 |
| 75 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.45937193 |
| 76 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.44857912 |
| 77 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.42654128 |
| 78 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.42491561 |
| 79 | GATA1_19941826_ChIP-Seq_K562_Human | 1.42367220 |
| 80 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.41736131 |
| 81 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.40869584 |
| 82 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.39535415 |
| 83 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.36351454 |
| 84 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.36285792 |
| 85 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.35475785 |
| 86 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.35275972 |
| 87 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.34939116 |
| 88 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.34025758 |
| 89 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.33202613 |
| 90 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.32383142 |
| 91 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.30813094 |
| 92 | * ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.30697146 |
| 93 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.30238731 |
| 94 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.30234503 |
| 95 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.30168452 |
| 96 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.30141797 |
| 97 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.30077644 |
| 98 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.28723557 |
| 99 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.28507666 |
| 100 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.27710700 |
| 101 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.27710700 |
| 102 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 1.27374671 |
| 103 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.25521143 |
| 104 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.24304821 |
| 105 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 1.23945729 |
| 106 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.23854763 |
| 107 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.23680575 |
| 108 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.23353794 |
| 109 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.23227325 |
| 110 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.23200206 |
| 111 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.23171036 |
| 112 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.22283309 |
| 113 | * FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.22275186 |
| 114 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.21944710 |
| 115 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.21808290 |
| 116 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.20926074 |
| 117 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.20815070 |
| 118 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.20729822 |
| 119 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.20500023 |
| 120 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.20145382 |
| 121 | * ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.19770215 |
| 122 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.19379073 |
| 123 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.19232161 |
| 124 | GATA2_19941826_ChIP-Seq_K562_Human | 1.18964255 |
| 125 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.18330431 |
| 126 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.17698631 |
| 127 | ATF3_27146783_Chip-Seq_COLON_Human | 1.17514276 |
| 128 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.17246851 |
| 129 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.16626223 |
| 130 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.16389594 |
| 131 | SPI1_23127762_ChIP-Seq_K562_Human | 1.15774528 |
| 132 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.15435159 |
| 133 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.15236085 |
| 134 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.14486414 |
| 135 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.14405463 |
| 136 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.13910595 |
| 137 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.13776056 |
| 138 | * TP63_22573176_ChIP-Seq_HFKS_Human | 1.12874367 |
| 139 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 1.12601708 |
| 140 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 1.11235181 |
| 141 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 1.10813857 |
| 142 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.09710987 |
| 143 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 1.09672529 |
| 144 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.09448417 |
| 145 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.09210868 |
| 146 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.08690488 |
| 147 | * NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.08630618 |
| 148 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.08127460 |
| 149 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.07071502 |
| 150 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.06440990 |
| 151 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.05736992 |
| 152 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.04930608 |
| 153 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 1.04830280 |
| 154 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.04114304 |
| 155 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.04114304 |
| 156 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.03940591 |
| 157 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.03121467 |
| 158 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.03107167 |
| 159 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.02566587 |
| 160 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.01922148 |
| 161 | SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 1.01698712 |
| 162 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.00491896 |
| 163 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.99835829 |
| 164 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.99751114 |
| 165 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.99714138 |
| 166 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.99671978 |
| 167 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.99136939 |
| 168 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.98514591 |
| 169 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.98248241 |
| 170 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.98169491 |
| 171 | * SPI1_23547873_ChIP-Seq_NB4_Human | 0.97749859 |
| 172 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.96211282 |
| 173 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.95057664 |
| 174 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.93594719 |
| 175 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.93390514 |
| 176 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.93206795 |
| 177 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.92564117 |
| 178 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.92488879 |
| 179 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.92183125 |
| 180 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.91407113 |
| 181 | * CTCF_27219007_Chip-Seq_Bcells_Human | 0.90741841 |
| 182 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.90120133 |
| 183 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.89847470 |
| 184 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.88924992 |
| 185 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.88259901 |
| 186 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.88028716 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003646_muscle_fatigue | 3.96174433 |
| 2 | MP0004036_abnormal_muscle_relaxation | 3.82981197 |
| 3 | MP0008438_abnormal_cutaneous_collagen | 3.69609382 |
| 4 | MP0003693_abnormal_embryo_hatching | 3.51965531 |
| 5 | MP0005451_abnormal_body_composition | 3.20889931 |
| 6 | MP0004957_abnormal_blastocyst_morpholog | 3.02102429 |
| 7 | MP0010352_gastrointestinal_tract_polyps | 2.98050288 |
| 8 | MP0003111_abnormal_nucleus_morphology | 2.61172078 |
| 9 | MP0003705_abnormal_hypodermis_morpholog | 2.61032096 |
| 10 | MP0002332_abnormal_exercise_endurance | 2.59383493 |
| 11 | MP0010094_abnormal_chromosome_stability | 2.50977049 |
| 12 | MP0005275_abnormal_skin_tensile | 2.34255645 |
| 13 | MP0003566_abnormal_cell_adhesion | 2.33300526 |
| 14 | MP0005620_abnormal_muscle_contractility | 2.33209200 |
| 15 | MP0003077_abnormal_cell_cycle | 2.24764320 |
| 16 | MP0002972_abnormal_cardiac_muscle | 2.22999483 |
| 17 | MP0005464_abnormal_platelet_physiology | 2.18730996 |
| 18 | MP0004510_myositis | 2.07951353 |
| 19 | MP0003279_aneurysm | 2.03905986 |
| 20 | MP0010307_abnormal_tumor_latency | 1.91404492 |
| 21 | MP0008057_abnormal_DNA_replication | 1.87360122 |
| 22 | MP0004130_abnormal_muscle_cell | 1.86930916 |
| 23 | MP0002837_dystrophic_cardiac_calcinosis | 1.86841659 |
| 24 | MP0008007_abnormal_cellular_replicative | 1.86290401 |
| 25 | MP0008932_abnormal_embryonic_tissue | 1.85272233 |
| 26 | MP0000750_abnormal_muscle_regeneration | 1.79162122 |
| 27 | MP0005623_abnormal_meninges_morphology | 1.77558083 |
| 28 | MP0002396_abnormal_hematopoietic_system | 1.77032088 |
| 29 | MP0000749_muscle_degeneration | 1.74244505 |
| 30 | MP0003191_abnormal_cellular_cholesterol | 1.74091240 |
| 31 | MP0008058_abnormal_DNA_repair | 1.70501415 |
| 32 | MP0001730_embryonic_growth_arrest | 1.70431901 |
| 33 | MP0000350_abnormal_cell_proliferation | 1.70052827 |
| 34 | MP0006036_abnormal_mitochondrial_physio | 1.65077973 |
| 35 | MP0004215_abnormal_myocardial_fiber | 1.63848977 |
| 36 | MP0005023_abnormal_wound_healing | 1.62383074 |
| 37 | MP0005503_abnormal_tendon_morphology | 1.57758338 |
| 38 | MP0009840_abnormal_foam_cell | 1.56818105 |
| 39 | MP0000751_myopathy | 1.54474536 |
| 40 | MP0003806_abnormal_nucleotide_metabolis | 1.53930453 |
| 41 | MP0003941_abnormal_skin_development | 1.53513625 |
| 42 | MP0004484_altered_response_of | 1.53038408 |
| 43 | MP0006138_congestive_heart_failure | 1.49351899 |
| 44 | MP0005076_abnormal_cell_differentiation | 1.47433810 |
| 45 | MP0000747_muscle_weakness | 1.45784518 |
| 46 | MP0004233_abnormal_muscle_weight | 1.45705442 |
| 47 | MP0002108_abnormal_muscle_morphology | 1.41303292 |
| 48 | MP0000490_abnormal_crypts_of | 1.40855012 |
| 49 | MP0004133_heterotaxia | 1.40280515 |
| 50 | MP0003786_premature_aging | 1.37976369 |
| 51 | MP0009780_abnormal_chondrocyte_physiolo | 1.37729758 |
| 52 | MP0000579_abnormal_nail_morphology | 1.37487765 |
| 53 | MP0001544_abnormal_cardiovascular_syste | 1.36455117 |
| 54 | MP0005385_cardiovascular_system_phenoty | 1.36455117 |
| 55 | MP0000858_altered_metastatic_potential | 1.36087753 |
| 56 | MP0009278_abnormal_bone_marrow | 1.33439435 |
| 57 | MP0008004_abnormal_stomach_pH | 1.33424896 |
| 58 | MP0002269_muscular_atrophy | 1.32202066 |
| 59 | MP0010030_abnormal_orbit_morphology | 1.32132374 |
| 60 | MP0005165_increased_susceptibility_to | 1.30361765 |
| 61 | MP0000759_abnormal_skeletal_muscle | 1.29418941 |
| 62 | MP0001697_abnormal_embryo_size | 1.28590996 |
| 63 | MP0008775_abnormal_heart_ventricle | 1.25675492 |
| 64 | MP0002060_abnormal_skin_morphology | 1.25522857 |
| 65 | MP0002080_prenatal_lethality | 1.25037643 |
| 66 | MP0001958_emphysema | 1.24407874 |
| 67 | MP0003567_abnormal_fetal_cardiomyocyte | 1.23898465 |
| 68 | MP0004197_abnormal_fetal_growth/weight/ | 1.22968403 |
| 69 | MP0005083_abnormal_biliary_tract | 1.22927105 |
| 70 | MP0001672_abnormal_embryogenesis/_devel | 1.21158103 |
| 71 | MP0005380_embryogenesis_phenotype | 1.21158103 |
| 72 | MP0000733_abnormal_muscle_development | 1.20528743 |
| 73 | MP0002086_abnormal_extraembryonic_tissu | 1.18507888 |
| 74 | MP0001542_abnormal_bone_strength | 1.18145656 |
| 75 | MP0004808_abnormal_hematopoietic_stem | 1.17550894 |
| 76 | MP0000013_abnormal_adipose_tissue | 1.16652005 |
| 77 | MP0008260_abnormal_autophagy | 1.15651413 |
| 78 | MP0005397_hematopoietic_system_phenotyp | 1.15386894 |
| 79 | MP0001545_abnormal_hematopoietic_system | 1.15386894 |
| 80 | MP0006054_spinal_hemorrhage | 1.14503675 |
| 81 | MP0002084_abnormal_developmental_patter | 1.13013426 |
| 82 | MP0003984_embryonic_growth_retardation | 1.12977927 |
| 83 | MP0004084_abnormal_cardiac_muscle | 1.12788372 |
| 84 | MP0002085_abnormal_embryonic_tissue | 1.12402789 |
| 85 | MP0002877_abnormal_melanocyte_morpholog | 1.11130953 |
| 86 | MP0002796_impaired_skin_barrier | 1.10861626 |
| 87 | MP0002088_abnormal_embryonic_growth/wei | 1.10607362 |
| 88 | MP0002106_abnormal_muscle_physiology | 1.10540830 |
| 89 | MP0004087_abnormal_muscle_fiber | 1.10193494 |
| 90 | MP0003453_abnormal_keratinocyte_physiol | 1.07738968 |
| 91 | MP0004272_abnormal_basement_membrane | 1.07286877 |
| 92 | MP0000358_abnormal_cell_content/ | 1.06693548 |
| 93 | MP0001849_ear_inflammation | 1.05196093 |
| 94 | MP0003656_abnormal_erythrocyte_physiolo | 1.03348559 |
| 95 | MP0005058_abnormal_lysosome_morphology | 1.02949711 |
| 96 | MP0001661_extended_life_span | 1.02892851 |
| 97 | MP0000343_altered_response_to | 1.01132702 |
| 98 | MP0000313_abnormal_cell_death | 0.99652637 |
| 99 | MP0002971_abnormal_brown_adipose | 0.96530658 |
| 100 | MP0003172_abnormal_lysosome_physiology | 0.95714535 |
| 101 | MP0002019_abnormal_tumor_incidence | 0.95334071 |
| 102 | MP0002127_abnormal_cardiovascular_syste | 0.93337732 |
| 103 | MP0003950_abnormal_plasma_membrane | 0.91758071 |
| 104 | MP0005369_muscle_phenotype | 0.91124994 |
| 105 | MP0005257_abnormal_intraocular_pressure | 0.90165968 |
| 106 | MP0001727_abnormal_embryo_implantation | 0.89884088 |
| 107 | MP0001243_abnormal_dermal_layer | 0.89828297 |
| 108 | MP0001915_intracranial_hemorrhage | 0.89459949 |
| 109 | MP0009333_abnormal_splenocyte_physiolog | 0.89022027 |
| 110 | MP0005508_abnormal_skeleton_morphology | 0.88301082 |
| 111 | MP0004381_abnormal_hair_follicle | 0.87996263 |
| 112 | MP0010234_abnormal_vibrissa_follicle | 0.85821132 |
| 113 | MP0003448_altered_tumor_morphology | 0.85401672 |
| 114 | MP0003075_altered_response_to | 0.85306367 |
| 115 | MP0004270_analgesia | 0.82061352 |
| 116 | MP0005375_adipose_tissue_phenotype | 0.80906579 |
| 117 | MP0005621_abnormal_cell_physiology | 0.80887749 |
| 118 | MP0010630_abnormal_cardiac_muscle | 0.80715792 |
| 119 | MP0005330_cardiomyopathy | 0.80587654 |
| 120 | MP0000467_abnormal_esophagus_morphology | 0.80537101 |
| 121 | MP0003828_pulmonary_edema | 0.80146170 |
| 122 | MP0003011_delayed_dark_adaptation | 0.79998418 |
| 123 | MP0005266_abnormal_metabolism | 0.79830846 |
| 124 | MP0004145_abnormal_muscle_electrophysio | 0.79215409 |
| 125 | MP0003091_abnormal_cell_migration | 0.78632145 |
| 126 | MP0002111_abnormal_tail_morphology | 0.77266896 |
| 127 | MP0000003_abnormal_adipose_tissue | 0.76963503 |
| 128 | MP0001348_abnormal_lacrimal_gland | 0.76358753 |
| 129 | MP0005367_renal/urinary_system_phenotyp | 0.76244000 |
| 130 | MP0000516_abnormal_urinary_system | 0.76244000 |
| 131 | MP0005666_abnormal_adipose_tissue | 0.75880958 |
| 132 | MP0003436_decreased_susceptibility_to | 0.75452641 |
| 133 | MP0005501_abnormal_skin_physiology | 0.74848451 |
| 134 | MP0005384_cellular_phenotype | 0.74771838 |
| 135 | MP0004858_abnormal_nervous_system | 0.74543781 |
| 136 | MP0000762_abnormal_tongue_morphology | 0.73332539 |
| 137 | MP0003283_abnormal_digestive_organ | 0.73311737 |
| 138 | MP0003221_abnormal_cardiomyocyte_apopto | 0.73300119 |
| 139 | MP0001293_anophthalmia | 0.73203167 |
| 140 | MP0000465_gastrointestinal_hemorrhage | 0.72695505 |
| 141 | MP0005166_decreased_susceptibility_to | 0.71346673 |
| 142 | MP0008770_decreased_survivor_rate | 0.70916920 |
| 143 | MP0000372_irregular_coat_pigmentation | 0.70250281 |
| 144 | MP0001853_heart_inflammation | 0.70094145 |
| 145 | MP0005174_abnormal_tail_pigmentation | 0.69753166 |
| 146 | MP0000371_diluted_coat_color | 0.69208290 |
| 147 | MP0009379_abnormal_foot_pigmentation | 0.68648473 |
| 148 | MP0000249_abnormal_blood_vessel | 0.62972394 |
| 149 | MP0003137_abnormal_impulse_conducting | 0.61874074 |
| 150 | MP0003879_abnormal_hair_cell | 0.61828069 |
| 151 | MP0003045_fibrosis | 0.61332825 |
| 152 | MP0004085_abnormal_heartbeat | 0.60962543 |
| 153 | MP0005167_abnormal_blood-brain_barrier | 0.60519364 |
| 154 | MP0002132_abnormal_respiratory_system | 0.59463502 |
| 155 | MP0002896_abnormal_bone_mineralization | 0.58334577 |
| 156 | MP0004185_abnormal_adipocyte_glucose | 0.57451918 |
| 157 | MP0005670_abnormal_white_adipose | 0.54377894 |
| 158 | MP0005409_darkened_coat_color | 0.54131600 |
| 159 | MP0008874_decreased_physiological_sensi | 0.54053672 |
| 160 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.53954073 |
| 161 | MP0000230_abnormal_systemic_arterial | 0.52817754 |
| 162 | MP0003638_abnormal_response/metabolism_ | 0.51570877 |
| 163 | MP0005319_abnormal_enzyme/_coenzyme | 0.51178430 |
| 164 | MP0001216_abnormal_epidermal_layer | 0.50693054 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Exercise-induced myalgia (HP:0003738) | 6.40761067 |
| 2 | Muscle hypertrophy of the lower extremities (HP:0008968) | 4.77106432 |
| 3 | Calf muscle hypertrophy (HP:0008981) | 4.46931543 |
| 4 | Protrusio acetabuli (HP:0003179) | 4.44869982 |
| 5 | EMG: myopathic abnormalities (HP:0003458) | 4.40982437 |
| 6 | Distal arthrogryposis (HP:0005684) | 4.10186734 |
| 7 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 4.06716457 |
| 8 | Asymmetric septal hypertrophy (HP:0001670) | 4.03566927 |
| 9 | Abnormality of the calf musculature (HP:0001430) | 3.99862304 |
| 10 | Neck muscle weakness (HP:0000467) | 3.95985816 |
| 11 | Abnormality of cells of the erythroid lineage (HP:0012130) | 3.74644591 |
| 12 | Premature rupture of membranes (HP:0001788) | 3.73750367 |
| 13 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 3.73074885 |
| 14 | Ulnar deviation of the wrist (HP:0003049) | 3.68389236 |
| 15 | Sudden death (HP:0001699) | 3.66148179 |
| 16 | Myoglobinuria (HP:0002913) | 3.64809248 |
| 17 | Muscle fiber inclusion bodies (HP:0100299) | 3.64750029 |
| 18 | Type 1 muscle fiber predominance (HP:0003803) | 3.59242058 |
| 19 | Nemaline bodies (HP:0003798) | 3.45611375 |
| 20 | Fatigable weakness (HP:0003473) | 3.39182520 |
| 21 | Abnormality of the neuromuscular junction (HP:0003398) | 3.39182520 |
| 22 | Increased variability in muscle fiber diameter (HP:0003557) | 3.30477110 |
| 23 | Abnormality of the left ventricular outflow tract (HP:0011103) | 3.21904749 |
| 24 | Subaortic stenosis (HP:0001682) | 3.21904749 |
| 25 | Abnormal number of erythroid precursors (HP:0012131) | 3.17355045 |
| 26 | Trismus (HP:0000211) | 3.15132665 |
| 27 | Weak cry (HP:0001612) | 3.14441234 |
| 28 | Increased connective tissue (HP:0009025) | 3.12607719 |
| 29 | Rimmed vacuoles (HP:0003805) | 3.10677432 |
| 30 | Reticulocytopenia (HP:0001896) | 3.10549197 |
| 31 | Abnormality of the calcaneus (HP:0008364) | 3.05655815 |
| 32 | Fetal akinesia sequence (HP:0001989) | 3.03833032 |
| 33 | Calcaneovalgus deformity (HP:0001848) | 3.02697462 |
| 34 | Gowers sign (HP:0003391) | 3.00145102 |
| 35 | Bundle branch block (HP:0011710) | 2.98350617 |
| 36 | Bulbar palsy (HP:0001283) | 2.96949042 |
| 37 | Abnormality of placental membranes (HP:0011409) | 2.96116060 |
| 38 | Amniotic constriction ring (HP:0009775) | 2.96116060 |
| 39 | Difficulty running (HP:0009046) | 2.95766150 |
| 40 | Ankle contracture (HP:0006466) | 2.90992442 |
| 41 | Muscle stiffness (HP:0003552) | 2.89614740 |
| 42 | Cervical subluxation (HP:0003308) | 2.86256811 |
| 43 | Distal lower limb muscle weakness (HP:0009053) | 2.85862222 |
| 44 | Difficulty climbing stairs (HP:0003551) | 2.83944135 |
| 45 | Vertebral compression fractures (HP:0002953) | 2.83737546 |
| 46 | Cerebral aneurysm (HP:0004944) | 2.77541207 |
| 47 | Selective tooth agenesis (HP:0001592) | 2.76275777 |
| 48 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.75779588 |
| 49 | Ventricular tachycardia (HP:0004756) | 2.72657974 |
| 50 | Round ear (HP:0100830) | 2.71888015 |
| 51 | Generalized muscle weakness (HP:0003324) | 2.69059363 |
| 52 | EMG: neuropathic changes (HP:0003445) | 2.68565307 |
| 53 | Wrist flexion contracture (HP:0001239) | 2.66739264 |
| 54 | Type 2 muscle fiber atrophy (HP:0003554) | 2.64500171 |
| 55 | Deformed tarsal bones (HP:0008119) | 2.64287904 |
| 56 | Agnosia (HP:0010524) | 2.57130207 |
| 57 | Spinal rigidity (HP:0003306) | 2.56789004 |
| 58 | Myopathic facies (HP:0002058) | 2.55735778 |
| 59 | Genu recurvatum (HP:0002816) | 2.48129528 |
| 60 | Breech presentation (HP:0001623) | 2.47246753 |
| 61 | Limb-girdle muscle atrophy (HP:0003797) | 2.47136607 |
| 62 | Colon cancer (HP:0003003) | 2.34994902 |
| 63 | Dilated cardiomyopathy (HP:0001644) | 2.34531857 |
| 64 | Pallor (HP:0000980) | 2.33919936 |
| 65 | Easy fatigability (HP:0003388) | 2.33062737 |
| 66 | Lipoatrophy (HP:0100578) | 2.29878005 |
| 67 | Absent thumb (HP:0009777) | 2.26093177 |
| 68 | Fragile skin (HP:0001030) | 2.25206716 |
| 69 | Carpal bone hypoplasia (HP:0001498) | 2.23839125 |
| 70 | Testicular atrophy (HP:0000029) | 2.22212726 |
| 71 | Soft skin (HP:0000977) | 2.21496686 |
| 72 | Exercise-induced muscle cramps (HP:0003710) | 2.17042735 |
| 73 | Scapular winging (HP:0003691) | 2.15281717 |
| 74 | Aplasia of the musculature (HP:0100854) | 2.14600733 |
| 75 | Macrocytic anemia (HP:0001972) | 2.12350774 |
| 76 | Malignant hyperthermia (HP:0002047) | 2.11906390 |
| 77 | Congenital hip dislocation (HP:0001374) | 2.11472292 |
| 78 | Lower limb amyotrophy (HP:0007210) | 2.11391387 |
| 79 | Distal upper limb amyotrophy (HP:0007149) | 2.09242001 |
| 80 | Upper limb amyotrophy (HP:0009129) | 2.09242001 |
| 81 | Rough bone trabeculation (HP:0100670) | 2.08980220 |
| 82 | Aplastic anemia (HP:0001915) | 2.08903592 |
| 83 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.08745432 |
| 84 | Aplasia/hypoplasia of the humerus (HP:0006507) | 2.08660962 |
| 85 | Hand muscle atrophy (HP:0009130) | 2.07387259 |
| 86 | Ventricular arrhythmia (HP:0004308) | 2.07233520 |
| 87 | Abnormal atrioventricular conduction (HP:0005150) | 2.06287889 |
| 88 | Atrophic scars (HP:0001075) | 2.06097629 |
| 89 | Areflexia of lower limbs (HP:0002522) | 2.04996144 |
| 90 | Birth length less than 3rd percentile (HP:0003561) | 2.04747281 |
| 91 | Popliteal pterygium (HP:0009756) | 2.04275264 |
| 92 | Muscle fibrillation (HP:0010546) | 2.03857937 |
| 93 | Peritonitis (HP:0002586) | 2.03029808 |
| 94 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 2.02995386 |
| 95 | Joint stiffness (HP:0001387) | 2.02555389 |
| 96 | Degeneration of anterior horn cells (HP:0002398) | 2.02072797 |
| 97 | Abnormality of the anterior horn cell (HP:0006802) | 2.02072797 |
| 98 | Slender build (HP:0001533) | 2.01296317 |
| 99 | Ependymoma (HP:0002888) | 2.01190789 |
| 100 | Spinal muscular atrophy (HP:0007269) | 2.00688117 |
| 101 | Breast hypoplasia (HP:0003187) | 1.99864249 |
| 102 | Slender long bone (HP:0003100) | 1.99445519 |
| 103 | Abnormal hemoglobin (HP:0011902) | 1.98943115 |
| 104 | Shallow orbits (HP:0000586) | 1.98855603 |
| 105 | Vertebral hypoplasia (HP:0008417) | 1.98700770 |
| 106 | Aplasia/Hypoplasia of the vertebrae (HP:0008515) | 1.98700770 |
| 107 | Short humerus (HP:0005792) | 1.98636910 |
| 108 | Heart block (HP:0012722) | 1.98256380 |
| 109 | Paralysis (HP:0003470) | 1.97439804 |
| 110 | Right ventricular cardiomyopathy (HP:0011663) | 1.96332740 |
| 111 | Abnormality of dentin (HP:0010299) | 1.96123043 |
| 112 | Purpura (HP:0000979) | 1.95321912 |
| 113 | Abnormal finger flexion creases (HP:0006143) | 1.95199269 |
| 114 | Rib fusion (HP:0000902) | 1.94421836 |
| 115 | Abnormality of the foot musculature (HP:0001436) | 1.91130202 |
| 116 | Nonprogressive disorder (HP:0003680) | 1.91020458 |
| 117 | Hyporeflexia of lower limbs (HP:0002600) | 1.90377910 |
| 118 | Progressive muscle weakness (HP:0003323) | 1.90236378 |
| 119 | Foot dorsiflexor weakness (HP:0009027) | 1.89702238 |
| 120 | Thin ribs (HP:0000883) | 1.87847446 |
| 121 | Petechiae (HP:0000967) | 1.87328311 |
| 122 | Myotonia (HP:0002486) | 1.86286812 |
| 123 | Wormian bones (HP:0002645) | 1.85743530 |
| 124 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.83616296 |
| 125 | Generalized amyotrophy (HP:0003700) | 1.82745363 |
| 126 | Increased density of long bones (HP:0006392) | 1.82660352 |
| 127 | Frequent falls (HP:0002359) | 1.82243098 |
| 128 | Pterygium (HP:0001059) | 1.82014158 |
| 129 | Fused cervical vertebrae (HP:0002949) | 1.81333251 |
| 130 | Hypoplasia of the pons (HP:0012110) | 1.80195142 |
| 131 | Beaking of vertebral bodies (HP:0004568) | 1.79354435 |
| 132 | Absent radius (HP:0003974) | 1.78464423 |
| 133 | Rhabdomyolysis (HP:0003201) | 1.78139256 |
| 134 | Muscle fiber splitting (HP:0003555) | 1.77343041 |
| 135 | Distal lower limb amyotrophy (HP:0008944) | 1.76199153 |
| 136 | Patellar aplasia (HP:0006443) | 1.75874323 |
| 137 | Menorrhagia (HP:0000132) | 1.75714791 |
| 138 | Increased cerebral lipofuscin (HP:0011813) | 1.74231243 |
| 139 | Stenosis of the external auditory canal (HP:0000402) | 1.73826667 |
| 140 | Waddling gait (HP:0002515) | 1.72900223 |
| 141 | Thrombocytosis (HP:0001894) | 1.72805498 |
| 142 | Prolonged bleeding time (HP:0003010) | 1.72701040 |
| 143 | Muscular dystrophy (HP:0003560) | 1.72542861 |
| 144 | Tongue fasciculations (HP:0001308) | 1.71639400 |
| 145 | Biconcave vertebral bodies (HP:0004586) | 1.71619094 |
| 146 | Abnormality of the acetabulum (HP:0003170) | 1.70901115 |
| 147 | Neoplasm of the pancreas (HP:0002894) | 1.70450873 |
| 148 | Muscle fiber atrophy (HP:0100295) | 1.70382563 |
| 149 | Missing ribs (HP:0000921) | 1.70088284 |
| 150 | Aplasia/Hypoplasia involving the carpal bones (HP:0006502) | 1.69590091 |
| 151 | Ventricular fibrillation (HP:0001663) | 1.69458368 |
| 152 | Absent phalangeal crease (HP:0006109) | 1.67884638 |
| 153 | Abnormality of the umbilical cord (HP:0010881) | 1.67554328 |
| 154 | Abnormality of the Achilles tendon (HP:0005109) | 1.66912682 |
| 155 | Ragged-red muscle fibers (HP:0003200) | 1.66072090 |
| 156 | Akinesia (HP:0002304) | 1.65574812 |
| 157 | Metaphyseal cupping (HP:0003021) | 1.65465146 |
| 158 | Hip contracture (HP:0003273) | 1.62807382 |
| 159 | Achilles tendon contracture (HP:0001771) | 1.62080350 |
| 160 | Axonal loss (HP:0003447) | 1.60960706 |
| 161 | Abnormality of glycolipid metabolism (HP:0010969) | 1.59229062 |
| 162 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.59229062 |
| 163 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.59229062 |
| 164 | Increased mean platelet volume (HP:0011877) | 1.54438515 |
| 165 | Exercise intolerance (HP:0003546) | 1.53765150 |
| 166 | Abnormal pupillary function (HP:0007686) | 1.50244439 |
| 167 | Hyperkalemia (HP:0002153) | 1.48273783 |
| 168 | Onycholysis (HP:0001806) | 1.47124003 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PHKG1 | 4.16263868 |
| 2 | PHKG2 | 4.16263868 |
| 3 | EPHA2 | 3.89048901 |
| 4 | NME2 | 3.29311638 |
| 5 | WEE1 | 2.97398325 |
| 6 | BUB1 | 2.80950485 |
| 7 | MUSK | 2.78081382 |
| 8 | TTN | 2.70665729 |
| 9 | PIM2 | 2.47177953 |
| 10 | MAPKAPK3 | 2.32424815 |
| 11 | NEK1 | 2.28671553 |
| 12 | RPS6KB2 | 2.21028801 |
| 13 | MYLK | 2.17992176 |
| 14 | PAK4 | 2.02693444 |
| 15 | EIF2AK1 | 2.00135773 |
| 16 | CDC7 | 1.97396373 |
| 17 | SCYL2 | 1.89233977 |
| 18 | CDK12 | 1.88962117 |
| 19 | LATS2 | 1.80148543 |
| 20 | MAPK12 | 1.69620336 |
| 21 | ARAF | 1.69144511 |
| 22 | TTK | 1.64632085 |
| 23 | TSSK6 | 1.64624024 |
| 24 | PKN2 | 1.62894987 |
| 25 | FLT3 | 1.59407871 |
| 26 | CDK7 | 1.57012048 |
| 27 | MAP2K3 | 1.55927367 |
| 28 | BCKDK | 1.49417791 |
| 29 | NEK2 | 1.48142015 |
| 30 | RPS6KA4 | 1.47558049 |
| 31 | ERN1 | 1.45635851 |
| 32 | EEF2K | 1.45362243 |
| 33 | EIF2AK3 | 1.43944988 |
| 34 | DDR2 | 1.40743837 |
| 35 | PLK1 | 1.29789931 |
| 36 | MAP3K3 | 1.28089655 |
| 37 | SIK1 | 1.26075764 |
| 38 | ZAK | 1.25831506 |
| 39 | ZAP70 | 1.25218575 |
| 40 | ACVR1B | 1.24487586 |
| 41 | MAP3K11 | 1.22002613 |
| 42 | LRRK2 | 1.20990347 |
| 43 | AURKA | 1.19773297 |
| 44 | TRPM7 | 1.19265595 |
| 45 | ATR | 1.18498350 |
| 46 | MAP3K8 | 1.13933162 |
| 47 | AURKB | 1.13879392 |
| 48 | OBSCN | 1.13679772 |
| 49 | TGFBR1 | 1.10957630 |
| 50 | RIPK1 | 1.09766830 |
| 51 | MAP3K12 | 1.09764501 |
| 52 | CHEK2 | 1.09116838 |
| 53 | TESK1 | 1.06381415 |
| 54 | EPHB1 | 1.05416197 |
| 55 | SRPK1 | 1.03650335 |
| 56 | MATK | 1.03004936 |
| 57 | CAMK2G | 1.02178447 |
| 58 | TRIB3 | 0.99224764 |
| 59 | MST4 | 0.98026938 |
| 60 | TLK1 | 0.97938773 |
| 61 | VRK1 | 0.96672706 |
| 62 | PIM1 | 0.93051279 |
| 63 | BRSK2 | 0.90647892 |
| 64 | PINK1 | 0.90185013 |
| 65 | TESK2 | 0.87764962 |
| 66 | DYRK3 | 0.86332315 |
| 67 | MTOR | 0.85361389 |
| 68 | CCNB1 | 0.84526487 |
| 69 | PASK | 0.83945498 |
| 70 | PAK1 | 0.82281733 |
| 71 | PTK2B | 0.82084557 |
| 72 | MAP3K6 | 0.80588145 |
| 73 | PLK3 | 0.79787340 |
| 74 | KDR | 0.78262606 |
| 75 | PIK3CG | 0.77556332 |
| 76 | CSNK2A2 | 0.77110936 |
| 77 | PDK2 | 0.76980498 |
| 78 | MAP3K7 | 0.76319217 |
| 79 | PLK4 | 0.75233574 |
| 80 | NEK9 | 0.75085749 |
| 81 | PAK2 | 0.74991249 |
| 82 | MAP2K1 | 0.74840430 |
| 83 | DMPK | 0.74651490 |
| 84 | MST1R | 0.74570519 |
| 85 | AKT2 | 0.73531279 |
| 86 | PDK4 | 0.71702128 |
| 87 | PDK3 | 0.71702128 |
| 88 | TAOK2 | 0.71034481 |
| 89 | STK38L | 0.71013547 |
| 90 | CDK6 | 0.70951264 |
| 91 | CDK8 | 0.69534767 |
| 92 | MAP3K1 | 0.69244655 |
| 93 | IRAK3 | 0.69169659 |
| 94 | LIMK1 | 0.68375832 |
| 95 | CHEK1 | 0.67647688 |
| 96 | MAP3K5 | 0.66969360 |
| 97 | PRKCI | 0.66947136 |
| 98 | LMTK2 | 0.66688264 |
| 99 | ABL2 | 0.66561249 |
| 100 | CSNK2A1 | 0.66176354 |
| 101 | TGFBR2 | 0.65144624 |
| 102 | ROCK1 | 0.63011957 |
| 103 | DAPK3 | 0.61947979 |
| 104 | MAP2K4 | 0.60669770 |
| 105 | PRKD1 | 0.60232731 |
| 106 | NME1 | 0.60140329 |
| 107 | BMX | 0.60030204 |
| 108 | STK10 | 0.59077176 |
| 109 | MOS | 0.57960960 |
| 110 | MAPK7 | 0.57434163 |
| 111 | KSR2 | 0.56183656 |
| 112 | RPS6KL1 | 0.56112163 |
| 113 | RPS6KC1 | 0.56112163 |
| 114 | MAP2K6 | 0.55587491 |
| 115 | RPS6KA6 | 0.55216868 |
| 116 | BLK | 0.54259652 |
| 117 | CAMK2D | 0.54168863 |
| 118 | ALK | 0.53515086 |
| 119 | DYRK1B | 0.53124698 |
| 120 | EPHB2 | 0.51789979 |
| 121 | PDGFRA | 0.51672243 |
| 122 | ATM | 0.51244189 |
| 123 | AKT3 | 0.51239219 |
| 124 | RPS6KA5 | 0.51194821 |
| 125 | CDK2 | 0.50706854 |
| 126 | ERBB3 | 0.50685502 |
| 127 | RIPK4 | 0.50222780 |
| 128 | ILK | 0.49646518 |
| 129 | YES1 | 0.49603583 |
| 130 | PDPK1 | 0.48742630 |
| 131 | MKNK1 | 0.48713382 |
| 132 | PRKAA2 | 0.46972230 |
| 133 | CDC42BPA | 0.46038234 |
| 134 | GRK7 | 0.45951403 |
| 135 | CDK4 | 0.45933280 |
| 136 | PRPF4B | 0.45545430 |
| 137 | BRD4 | 0.45531857 |
| 138 | FER | 0.45294727 |
| 139 | MAP3K2 | 0.44336163 |
| 140 | MAPKAPK2 | 0.44232794 |
| 141 | GRK6 | 0.43931827 |
| 142 | TAOK1 | 0.43733296 |
| 143 | MARK2 | 0.43120641 |
| 144 | PTK2 | 0.43113186 |
| 145 | MET | 0.42459688 |
| 146 | MAPK4 | 0.42427705 |
| 147 | DAPK1 | 0.41438901 |
| 148 | TBK1 | 0.41437603 |
| 149 | MAPK11 | 0.39279014 |
| 150 | IKBKB | 0.38667346 |
| 151 | MAP3K13 | 0.38054967 |
| 152 | PRKD2 | 0.37925987 |
| 153 | ROCK2 | 0.37007733 |
| 154 | BTK | 0.36114986 |
| 155 | MAPK15 | 0.36028251 |
| 156 | GRK5 | 0.35396802 |
| 157 | RPS6KA2 | 0.34226402 |
| 158 | CAMK2B | 0.33352591 |
| 159 | PKN1 | 0.32793051 |
| 160 | CSK | 0.31360972 |
| 161 | PRKG1 | 0.30482352 |
| 162 | ICK | 0.30295020 |
| 163 | PRKAA1 | 0.29451374 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ribosome_Homo sapiens_hsa03010 | 3.98738132 |
| 2 | DNA replication_Homo sapiens_hsa03030 | 3.83448566 |
| 3 | Mismatch repair_Homo sapiens_hsa03430 | 3.61341913 |
| 4 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 3.42087660 |
| 5 | Proteasome_Homo sapiens_hsa03050 | 3.25292401 |
| 6 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.89668930 |
| 7 | RNA polymerase_Homo sapiens_hsa03020 | 2.65380670 |
| 8 | RNA transport_Homo sapiens_hsa03013 | 2.57699929 |
| 9 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.48707688 |
| 10 | Base excision repair_Homo sapiens_hsa03410 | 2.44878517 |
| 11 | Nucleotide excision repair_Homo sapiens_hsa03420 | 2.41075747 |
| 12 | Spliceosome_Homo sapiens_hsa03040 | 2.40799432 |
| 13 | One carbon pool by folate_Homo sapiens_hsa00670 | 2.28410492 |
| 14 | Homologous recombination_Homo sapiens_hsa03440 | 2.17611012 |
| 15 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.86688936 |
| 16 | Cell cycle_Homo sapiens_hsa04110 | 1.80578596 |
| 17 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.70105609 |
| 18 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.67583830 |
| 19 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.64793088 |
| 20 | Circadian rhythm_Homo sapiens_hsa04710 | 1.54937495 |
| 21 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.53391471 |
| 22 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.46212380 |
| 23 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.45192758 |
| 24 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.40359286 |
| 25 | * Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.39169862 |
| 26 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.37172928 |
| 27 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.32008422 |
| 28 | Platelet activation_Homo sapiens_hsa04611 | 1.28648739 |
| 29 | RNA degradation_Homo sapiens_hsa03018 | 1.27151305 |
| 30 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.25245824 |
| 31 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.24118961 |
| 32 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.24069964 |
| 33 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.22685238 |
| 34 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.20433468 |
| 35 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.16246230 |
| 36 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.15199791 |
| 37 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.14995073 |
| 38 | Insulin resistance_Homo sapiens_hsa04931 | 1.12649993 |
| 39 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.07057872 |
| 40 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.04208515 |
| 41 | Bladder cancer_Homo sapiens_hsa05219 | 1.03422315 |
| 42 | Basal transcription factors_Homo sapiens_hsa03022 | 1.03237364 |
| 43 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.03028672 |
| 44 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.98622844 |
| 45 | Legionellosis_Homo sapiens_hsa05134 | 0.98482749 |
| 46 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.98005844 |
| 47 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.97117461 |
| 48 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.96609752 |
| 49 | Parkinsons disease_Homo sapiens_hsa05012 | 0.95753716 |
| 50 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.93622889 |
| 51 | Other glycan degradation_Homo sapiens_hsa00511 | 0.92346907 |
| 52 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.92263071 |
| 53 | Huntingtons disease_Homo sapiens_hsa05016 | 0.91749070 |
| 54 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.90499432 |
| 55 | Shigellosis_Homo sapiens_hsa05131 | 0.90294348 |
| 56 | Purine metabolism_Homo sapiens_hsa00230 | 0.89935291 |
| 57 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.88514036 |
| 58 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.87503875 |
| 59 | Adherens junction_Homo sapiens_hsa04520 | 0.87336413 |
| 60 | Thyroid cancer_Homo sapiens_hsa05216 | 0.86420123 |
| 61 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.86306867 |
| 62 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.85566162 |
| 63 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.84214782 |
| 64 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.83593800 |
| 65 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.83025946 |
| 66 | Protein export_Homo sapiens_hsa03060 | 0.82757033 |
| 67 | Apoptosis_Homo sapiens_hsa04210 | 0.82486248 |
| 68 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.82203093 |
| 69 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.82194472 |
| 70 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.81387415 |
| 71 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.80400885 |
| 72 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.78799429 |
| 73 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.76217623 |
| 74 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.75771406 |
| 75 | HTLV-I infection_Homo sapiens_hsa05166 | 0.75706191 |
| 76 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.74939045 |
| 77 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.74802829 |
| 78 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.74274035 |
| 79 | Phagosome_Homo sapiens_hsa04145 | 0.73743584 |
| 80 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.72505540 |
| 81 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.71885634 |
| 82 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.71784908 |
| 83 | Focal adhesion_Homo sapiens_hsa04510 | 0.71442050 |
| 84 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.70223571 |
| 85 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.68643672 |
| 86 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.65779324 |
| 87 | Endocytosis_Homo sapiens_hsa04144 | 0.65577467 |
| 88 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.65240769 |
| 89 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.64213381 |
| 90 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.64037076 |
| 91 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.62951292 |
| 92 | Lysosome_Homo sapiens_hsa04142 | 0.61732516 |
| 93 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.61347992 |
| 94 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.60362673 |
| 95 | Tight junction_Homo sapiens_hsa04530 | 0.59936273 |
| 96 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.58703524 |
| 97 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.58092067 |
| 98 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.57692347 |
| 99 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.57477915 |
| 100 | Alzheimers disease_Homo sapiens_hsa05010 | 0.57247917 |
| 101 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.56811947 |
| 102 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.55346032 |
| 103 | Malaria_Homo sapiens_hsa05144 | 0.55345283 |
| 104 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.55020558 |
| 105 | Renin secretion_Homo sapiens_hsa04924 | 0.54448861 |
| 106 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.54112791 |
| 107 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.54003890 |
| 108 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.53661317 |
| 109 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.53161044 |
| 110 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.52642059 |
| 111 | Carbon metabolism_Homo sapiens_hsa01200 | 0.52359914 |
| 112 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.51772497 |
| 113 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.51731698 |
| 114 | Peroxisome_Homo sapiens_hsa04146 | 0.51639799 |
| 115 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.51409683 |
| 116 | Viral myocarditis_Homo sapiens_hsa05416 | 0.50522437 |
| 117 | Amoebiasis_Homo sapiens_hsa05146 | 0.50232161 |
| 118 | Galactose metabolism_Homo sapiens_hsa00052 | 0.48800456 |
| 119 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.48417305 |
| 120 | Histidine metabolism_Homo sapiens_hsa00340 | 0.48082160 |
| 121 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.47604881 |
| 122 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.47270312 |
| 123 | Leishmaniasis_Homo sapiens_hsa05140 | 0.47159445 |
| 124 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.46581864 |
| 125 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.46267966 |
| 126 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.46070038 |
| 127 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.45832374 |
| 128 | Melanoma_Homo sapiens_hsa05218 | 0.44230189 |
| 129 | Pathways in cancer_Homo sapiens_hsa05200 | 0.44080162 |
| 130 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.43834667 |
| 131 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.43385423 |
| 132 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.43323079 |
| 133 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.43279581 |
| 134 | Tuberculosis_Homo sapiens_hsa05152 | 0.43138958 |
| 135 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.43033081 |
| 136 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.42762132 |
| 137 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.42671884 |
| 138 | Prion diseases_Homo sapiens_hsa05020 | 0.41628913 |
| 139 | Salmonella infection_Homo sapiens_hsa05132 | 0.41443581 |
| 140 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.41040736 |
| 141 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.40323136 |
| 142 | Hepatitis B_Homo sapiens_hsa05161 | 0.39608587 |
| 143 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.37860372 |
| 144 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.37000056 |
| 145 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.36618491 |
| 146 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.35270171 |
| 147 | Sulfur relay system_Homo sapiens_hsa04122 | 0.34391089 |
| 148 | Pertussis_Homo sapiens_hsa05133 | 0.33977026 |
| 149 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.33865152 |
| 150 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.32838939 |
| 151 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.32636305 |
| 152 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.32176564 |
| 153 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.30662301 |
| 154 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.29607644 |
| 155 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.29325499 |
| 156 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.27479256 |

